CardioComm Solutions, Inc. Stock

Equities

EKG

CA14159N2086

Advanced Medical Equipment & Technology

Delayed Toronto S.E. 11:14:17 2024-04-16 am EDT 5-day change 1st Jan Change
0.01 CAD 0.00% Intraday chart for CardioComm Solutions, Inc. 0.00% 0.00%
Sales 2021 683K 499K Sales 2022 996K 729K Capitalization 3.77M 2.76M
Net income 2021 - 0 Net income 2022 - 0 EV / Sales 2021 7.09 x
Net Debt 2021 330K 241K Net Debt 2022 288K 211K EV / Sales 2022 4.08 x
P/E ratio 2021
30,000 x
P/E ratio 2022
-1,563 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 61.88%
More Fundamentals * Assessed data
Dynamic Chart
CardioComm Solutions, Inc. Appoint Robin Black to Board of Directors CI
Cardiocomm Solutions, Inc. Announces CFO Changes CI
CardioComm Solutions, Inc. Resumes Full Operations Following Cyber Attack CI
CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
CardioComm Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
CardioComm Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
CardioComm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CardioComm Solutions, Inc. Announces Executive Changes CI
CardioComm Solutions, Inc. Confirms Technology Integration Agreement with Utah-Based Carexm LLC CI
CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
CardioComm Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
CardioComm Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
CardioComm Solutions, Inc. Auditor Raises 'Going Concern' Doubt CI
CardioComm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
More news
3 months+100.00%
6 months-50.00%
More quotes
1 month
0.01
Extreme 0.01
0.01
Current year
0.01
Extreme 0.005
0.02
1 year
0.01
Extreme 0.005
0.02
3 years
0.01
Extreme 0.005
0.06
5 years
0.00
Extreme 0
0.11
10 years
0.00
Extreme 0
0.14
More quotes
Managers TitleAgeSince
Chief Executive Officer - 06-11-28
Chairman - 15-12-15
Chief Tech/Sci/R&D Officer - 14-08-05
Members of the board TitleAgeSince
Chief Executive Officer - 06-11-28
Chairman - 15-12-15
Director/Board Member - -
More insiders
Date Price Change Volume

Delayed Quote Toronto S.E., April 16, 2024 at 11:14 am EDT

More quotes
CardioComm Solutions, Inc. is a Canada-based company, which develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company's specialization is in the software engineering of computer based (ECG) management and reporting software. The software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings. The Company’s device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for the recording, transmission, viewing, analyzing, reporting and storage of electrocardiograms, for arrhythmia screening, diagnosis, and management of cardiac patients. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians.
More about the company